| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 27 | 2026 | 361 | 6.130 |
Why?
|
| Infant, Premature | 15 | 2026 | 872 | 2.900 |
Why?
|
| Infant, Newborn | 59 | 2026 | 8635 | 2.110 |
Why?
|
| Infant, Premature, Diseases | 7 | 2024 | 255 | 2.000 |
Why?
|
| Hypoxia-Ischemia, Brain | 11 | 2025 | 95 | 1.940 |
Why?
|
| Infant, Extremely Premature | 8 | 2024 | 113 | 1.500 |
Why?
|
| Noise | 2 | 2023 | 17 | 1.420 |
Why?
|
| Bronchopulmonary Dysplasia | 6 | 2026 | 222 | 1.290 |
Why?
|
| Erythropoietin | 6 | 2022 | 102 | 1.270 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2021 | 177 | 1.180 |
Why?
|
| Gestational Age | 14 | 2025 | 1224 | 1.180 |
Why?
|
| Hypothermia, Induced | 7 | 2025 | 172 | 1.100 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 229 | 1.040 |
Why?
|
| Child Development | 3 | 2023 | 266 | 1.010 |
Why?
|
| Lung Diseases | 2 | 2022 | 398 | 0.960 |
Why?
|
| Heart Arrest | 2 | 2021 | 356 | 0.930 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2025 | 514 | 0.890 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 16 | 0.880 |
Why?
|
| Parents | 5 | 2026 | 1128 | 0.790 |
Why?
|
| Hypoglycemia | 3 | 2021 | 190 | 0.780 |
Why?
|
| Infant | 26 | 2025 | 13352 | 0.770 |
Why?
|
| Anticonvulsants | 2 | 2024 | 363 | 0.740 |
Why?
|
| Vasodilator Agents | 2 | 2026 | 197 | 0.720 |
Why?
|
| Tocolytic Agents | 1 | 2022 | 11 | 0.720 |
Why?
|
| Brain Diseases | 1 | 2025 | 299 | 0.710 |
Why?
|
| Needs Assessment | 1 | 2023 | 173 | 0.710 |
Why?
|
| Phenobarbital | 1 | 2021 | 32 | 0.700 |
Why?
|
| Visitors to Patients | 1 | 2020 | 9 | 0.650 |
Why?
|
| Incubators, Infant | 1 | 2020 | 4 | 0.650 |
Why?
|
| Papaver | 1 | 2020 | 4 | 0.640 |
Why?
|
| Hospital Administration | 1 | 2020 | 24 | 0.640 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 205 | 0.640 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.620 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 60 | 0.610 |
Why?
|
| Neonatology | 3 | 2025 | 66 | 0.610 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 63 | 0.600 |
Why?
|
| Neuroprotection | 1 | 2019 | 31 | 0.600 |
Why?
|
| Humans | 62 | 2026 | 131163 | 0.600 |
Why?
|
| Infection Control | 1 | 2020 | 158 | 0.580 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 63 | 0.570 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 41 | 0.570 |
Why?
|
| United States | 16 | 2026 | 12072 | 0.560 |
Why?
|
| Hypernatremia | 1 | 2019 | 32 | 0.560 |
Why?
|
| Epoprostenol | 1 | 2018 | 33 | 0.560 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 400 | 0.550 |
Why?
|
| Hyponatremia | 1 | 2019 | 73 | 0.540 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 262 | 0.540 |
Why?
|
| Infant, Low Birth Weight | 4 | 2025 | 172 | 0.540 |
Why?
|
| Sodium | 1 | 2019 | 280 | 0.530 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 155 | 0.520 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 83 | 0.510 |
Why?
|
| Betacoronavirus | 1 | 2020 | 275 | 0.510 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17753 | 0.470 |
Why?
|
| Nitric Oxide | 2 | 2018 | 471 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.450 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 623 | 0.450 |
Why?
|
| Neonatologists | 2 | 2025 | 22 | 0.440 |
Why?
|
| Resuscitation | 1 | 2017 | 258 | 0.440 |
Why?
|
| Female | 35 | 2026 | 70963 | 0.440 |
Why?
|
| Pregnancy | 12 | 2025 | 7512 | 0.430 |
Why?
|
| Mass Screening | 1 | 2020 | 822 | 0.420 |
Why?
|
| Hemorrhage | 1 | 2018 | 487 | 0.410 |
Why?
|
| Patient Selection | 3 | 2026 | 729 | 0.410 |
Why?
|
| Biomedical Research | 3 | 2026 | 561 | 0.400 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.390 |
Why?
|
| Electroencephalography | 4 | 2025 | 863 | 0.380 |
Why?
|
| Hypothermia | 2 | 2023 | 62 | 0.370 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3829 | 0.360 |
Why?
|
| Milk, Human | 3 | 2021 | 321 | 0.360 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 4066 | 0.350 |
Why?
|
| Typhoid Fever | 1 | 2011 | 17 | 0.350 |
Why?
|
| Salmonella typhi | 1 | 2011 | 19 | 0.350 |
Why?
|
| Retinopathy of Prematurity | 2 | 2024 | 65 | 0.340 |
Why?
|
| Male | 27 | 2026 | 64957 | 0.330 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 157 | 0.310 |
Why?
|
| Informed Consent | 2 | 2026 | 351 | 0.300 |
Why?
|
| Prevalence | 4 | 2025 | 2701 | 0.290 |
Why?
|
| Texas | 3 | 2025 | 3686 | 0.280 |
Why?
|
| Dietary Supplements | 4 | 2024 | 448 | 0.270 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 629 | 0.250 |
Why?
|
| Decision Making | 3 | 2026 | 726 | 0.250 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2026 | 34 | 0.240 |
Why?
|
| Premature Birth | 2 | 2022 | 428 | 0.240 |
Why?
|
| Sildenafil Citrate | 1 | 2026 | 56 | 0.240 |
Why?
|
| Sulfones | 1 | 2026 | 72 | 0.230 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 86 | 0.230 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2026 | 63 | 0.220 |
Why?
|
| Syphilis, Congenital | 1 | 2025 | 32 | 0.220 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2026 | 80 | 0.220 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2025 | 136 | 0.220 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2025 | 87 | 0.210 |
Why?
|
| Piperazines | 1 | 2026 | 265 | 0.210 |
Why?
|
| Research Personnel | 1 | 2025 | 139 | 0.200 |
Why?
|
| Incubators | 1 | 2023 | 2 | 0.200 |
Why?
|
| Sound | 1 | 2023 | 19 | 0.200 |
Why?
|
| Seizures | 3 | 2024 | 890 | 0.200 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 82 | 0.200 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 88 | 0.190 |
Why?
|
| Birth Weight | 3 | 2022 | 347 | 0.190 |
Why?
|
| Weight Gain | 2 | 2023 | 393 | 0.190 |
Why?
|
| Oximetry | 1 | 2024 | 176 | 0.190 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 37 | 0.190 |
Why?
|
| Vitamin D | 1 | 2024 | 194 | 0.180 |
Why?
|
| Palivizumab | 1 | 2022 | 49 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2025 | 5063 | 0.180 |
Why?
|
| Tocolysis | 1 | 2022 | 5 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 109 | 0.180 |
Why?
|
| Administration, Intravenous | 2 | 2022 | 173 | 0.180 |
Why?
|
| Mothers | 1 | 2025 | 388 | 0.170 |
Why?
|
| Status Epilepticus | 1 | 2023 | 159 | 0.170 |
Why?
|
| Magnesium Sulfate | 1 | 2022 | 53 | 0.170 |
Why?
|
| Phenytoin | 1 | 2021 | 54 | 0.170 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2022 | 81 | 0.170 |
Why?
|
| Double-Blind Method | 5 | 2026 | 1626 | 0.170 |
Why?
|
| Refusal to Participate | 1 | 2021 | 3 | 0.170 |
Why?
|
| Breast Feeding | 2 | 2021 | 240 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 157 | 0.160 |
Why?
|
| Parental Consent | 1 | 2021 | 24 | 0.160 |
Why?
|
| Patients' Rooms | 1 | 2020 | 8 | 0.160 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 12 | 0.160 |
Why?
|
| Placenta Diseases | 1 | 2021 | 55 | 0.160 |
Why?
|
| Probiotics | 1 | 2023 | 227 | 0.160 |
Why?
|
| Equipment Safety | 1 | 2020 | 34 | 0.160 |
Why?
|
| Tea | 1 | 2020 | 17 | 0.160 |
Why?
|
| Oxygen | 1 | 2024 | 548 | 0.160 |
Why?
|
| Infant Health | 1 | 2020 | 17 | 0.160 |
Why?
|
| Policy Making | 1 | 2020 | 63 | 0.160 |
Why?
|
| Organizational Policy | 1 | 2020 | 50 | 0.160 |
Why?
|
| Codeine | 1 | 2020 | 23 | 0.160 |
Why?
|
| Manikins | 1 | 2020 | 44 | 0.160 |
Why?
|
| Echoencephalography | 1 | 2020 | 28 | 0.160 |
Why?
|
| Cholestasis | 1 | 2022 | 170 | 0.160 |
Why?
|
| Seeds | 1 | 2020 | 44 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2025 | 536 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 81 | 0.160 |
Why?
|
| Registries | 2 | 2025 | 1634 | 0.150 |
Why?
|
| Drug Evaluation | 1 | 2019 | 101 | 0.150 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2019 | 3 | 0.150 |
Why?
|
| Child, Preschool | 7 | 2025 | 15110 | 0.150 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 21 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 150 | 0.150 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 212 | 0.150 |
Why?
|
| Rhombencephalon | 2 | 2009 | 63 | 0.150 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 44 | 0.140 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 176 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2020 | 294 | 0.140 |
Why?
|
| Physicians | 1 | 2025 | 635 | 0.140 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 86 | 0.140 |
Why?
|
| Food, Fortified | 1 | 2018 | 64 | 0.140 |
Why?
|
| Eye Diseases | 1 | 2019 | 107 | 0.130 |
Why?
|
| Eating | 1 | 2020 | 377 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 193 | 0.130 |
Why?
|
| Pulmonary Surfactants | 1 | 2018 | 45 | 0.130 |
Why?
|
| Phospholipids | 1 | 2018 | 100 | 0.130 |
Why?
|
| Hospitals | 1 | 2020 | 435 | 0.120 |
Why?
|
| Brain Injuries | 1 | 2022 | 710 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2020 | 385 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2022 | 807 | 0.120 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 401 | 0.120 |
Why?
|
| Infant Mortality | 1 | 2018 | 183 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 290 | 0.120 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1129 | 0.120 |
Why?
|
| Biological Products | 1 | 2018 | 145 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 333 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2026 | 12936 | 0.110 |
Why?
|
| Adult | 6 | 2026 | 31282 | 0.110 |
Why?
|
| Liver | 1 | 2002 | 1796 | 0.110 |
Why?
|
| Child | 4 | 2024 | 26341 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1590 | 0.110 |
Why?
|
| Glucose | 1 | 2019 | 853 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 705 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2026 | 3061 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1797 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1117 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2019 | 1240 | 0.100 |
Why?
|
| Sex Factors | 1 | 2018 | 1356 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 853 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 715 | 0.100 |
Why?
|
| Hospitalization | 1 | 2022 | 1950 | 0.100 |
Why?
|
| Epilepsy | 1 | 2021 | 876 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2025 | 1267 | 0.090 |
Why?
|
| Trust | 2 | 2026 | 91 | 0.090 |
Why?
|
| Biomarkers | 2 | 2020 | 3385 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3359 | 0.090 |
Why?
|
| Pakistan | 1 | 2011 | 99 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2026 | 1618 | 0.080 |
Why?
|
| Proprioception | 1 | 2009 | 17 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 48 | 0.080 |
Why?
|
| Arousal | 1 | 2009 | 75 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1889 | 0.070 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 80 | 0.070 |
Why?
|
| Time Factors | 1 | 2018 | 6196 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2008 | 185 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1489 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 146 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2008 | 255 | 0.060 |
Why?
|
| Risk Factors | 3 | 2022 | 11074 | 0.060 |
Why?
|
| Neonatal Nursing | 1 | 2026 | 7 | 0.060 |
Why?
|
| Asphyxia Neonatorum | 1 | 2025 | 23 | 0.060 |
Why?
|
| Brain | 3 | 2024 | 3175 | 0.060 |
Why?
|
| Purines | 1 | 2026 | 118 | 0.060 |
Why?
|
| Research Support as Topic | 1 | 2025 | 61 | 0.060 |
Why?
|
| Penicillins | 1 | 2025 | 154 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2025 | 100 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2021 | 6459 | 0.050 |
Why?
|
| Hypotension | 1 | 2026 | 187 | 0.050 |
Why?
|
| Mother-Child Relations | 1 | 2025 | 84 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2026 | 466 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 702 | 0.050 |
Why?
|
| Career Choice | 1 | 2025 | 166 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 283 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2024 | 276 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 245 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 1979 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2009 | 3819 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 22 | 0.050 |
Why?
|
| Asphyxia | 1 | 2022 | 15 | 0.050 |
Why?
|
| Hepcidins | 1 | 2002 | 26 | 0.050 |
Why?
|
| Olive Oil | 1 | 2022 | 24 | 0.050 |
Why?
|
| Indomethacin | 1 | 2022 | 79 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2022 | 71 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 87 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2026 | 730 | 0.040 |
Why?
|
| Fish Oils | 1 | 2022 | 82 | 0.040 |
Why?
|
| Albuminuria | 1 | 2022 | 107 | 0.040 |
Why?
|
| Bilirubin | 1 | 2022 | 126 | 0.040 |
Why?
|
| Spleen | 1 | 2002 | 258 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3763 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2021 | 82 | 0.040 |
Why?
|
| Patient Safety | 1 | 2025 | 443 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5196 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2019 | 5 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 262 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 602 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 66 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1421 | 0.040 |
Why?
|
| Pacifiers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 304 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2019 | 59 | 0.040 |
Why?
|
| Animals | 5 | 2025 | 33912 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2009 | 200 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 68 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 108 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 170 | 0.030 |
Why?
|
| Acute Disease | 1 | 2021 | 1153 | 0.030 |
Why?
|
| Vomiting | 1 | 2018 | 103 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 437 | 0.030 |
Why?
|
| Incidence | 1 | 2025 | 3360 | 0.030 |
Why?
|
| Acidosis | 1 | 2018 | 97 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 514 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 789 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 563 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2019 | 243 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 345 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 18301 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2550 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2021 | 1246 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 387 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 425 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 4886 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2025 | 3711 | 0.030 |
Why?
|
| Cell Movement | 2 | 2009 | 876 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 943 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2326 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2596 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Auditory Pathways | 1 | 2009 | 20 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 48 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 60 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2009 | 39 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 24 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 69 | 0.020 |
Why?
|
| Levodopa | 1 | 2009 | 92 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 28 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 358 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 808 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 270 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 437 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 206 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 254 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 555 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 28601 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2406 | 0.010 |
Why?
|